Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 451
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 101–115 of 115 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06353906	Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer(PRIAM)	recruiting	Phase 2	27	The Netherlands Cancer InstituteOTHER	2	Dec 8, 2025	clinicaltrials
NCT05526989	Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma	recruiting	Phase 2	25	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Dec 4, 2025